Literature DB >> 10068370

Impaired glucose tolerance in HIV-positive patients receiving and those not receiving protease inhibitors.

S Mauss, E Wolf, H Jaeger.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1999        PMID： 10068370     DOI： 10.7326/0003-4819-130-2-199901190-00019

Source DB:  PubMed          Journal:  Ann Intern Med        ISSN： 0003-4819            Impact factor:   25.391


× No keyword cloud information.
  2 in total

1.  Protease inhibitor related type III hyperlipoproteinaemia is common and not associated with apolipoprotein-E E2/E2 phenotype.

Authors:  M Shahmanesh; H Jaleel; Y DeSilva; J D Ross; M Caslake; R Cramb
Journal:  Sex Transm Infect       Date:  2001-08       Impact factor: 3.519

Review 2.  Lipodystrophy syndrome in HIV infection: what is it, what causes it and how can it be managed?

Authors:  G M Behrens; M Stoll; R E Schmidt
Journal:  Drug Saf       Date:  2000-07       Impact factor: 5.606
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.